Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Edward Thomas Ryan, D.T.M.&H., M.D.

Co-Author

This page shows the publications co-authored by Edward Ryan and Stephen Calderwood.
Connection Strength

11.673
  1. Scalable production and immunogenicity of a cholera conjugate vaccine. Vaccine. 2021 11 16; 39(47):6936-6946.
    View in: PubMed
    Score: 0.242
  2. Systemic, Mucosal, and Memory Immune Responses following Cholera. Trop Med Infect Dis. 2021 Oct 27; 6(4).
    View in: PubMed
    Score: 0.242
  3. Local production of anti-vibrio cholerae mucosal antibody in reproductive tract tissues after cholera. J Infect Dis. 2001 Sep 01; 184(5):643-7.
    View in: PubMed
    Score: 0.238
  4. Correction: Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis. 2021 Jul; 15(7):e0009616.
    View in: PubMed
    Score: 0.237
  5. Defining Polysaccharide-Specific Antibody Targets against Vibrio cholerae O139 in Humans following O139 Cholera and following Vaccination with a Commercial Bivalent Oral Cholera Vaccine, and Evaluation of Conjugate Vaccines Targeting O139. mSphere. 2021 08 25; 6(4):e0011421.
    View in: PubMed
    Score: 0.237
  6. Parenteral Vaccination with a Cholera Conjugate Vaccine Boosts Vibriocidal and Anti-OSP Responses in Mice Previously Immunized with an Oral Cholera Vaccine. Am J Trop Med Hyg. 2021 04 19; 104(6):2024-2030.
    View in: PubMed
    Score: 0.233
  7. Cholera vaccines. J Travel Med. 2001 Mar-Apr; 8(2):82-91.
    View in: PubMed
    Score: 0.231
  8. Humans Surviving Cholera Develop Antibodies against Vibrio cholerae O-Specific Polysaccharide That Inhibit Pathogen Motility. mBio. 2020 11 17; 11(6).
    View in: PubMed
    Score: 0.226
  9. Cholera vaccines. Clin Infect Dis. 2000 Aug; 31(2):561-5.
    View in: PubMed
    Score: 0.223
  10. Transcutaneous Vaccination with Conjugate Typhoid Vaccine Vi-DT Induces Systemic, Mucosal, and Memory Anti-Polysaccharide Responses. Am J Trop Med Hyg. 2020 09; 103(3):1032-1038.
    View in: PubMed
    Score: 0.223
  11. Development of a DeltaglnA balanced lethal plasmid system for expression of heterologous antigens by attenuated vaccine vector strains of Vibrio cholerae. Infect Immun. 2000 Jan; 68(1):221-6.
    View in: PubMed
    Score: 0.213
  12. Immune responses to O-specific polysaccharide (OSP) in North American adults infected with Vibrio cholerae O1 Inaba. PLoS Negl Trop Dis. 2019 11; 13(11):e0007874.
    View in: PubMed
    Score: 0.211
  13. In vivo expression and immunoadjuvancy of a mutant of heat-labile enterotoxin of Escherichia coli in vaccine and vector strains of Vibrio cholerae. Infect Immun. 1999 Apr; 67(4):1694-701.
    View in: PubMed
    Score: 0.202
  14. Plasma and memory B cell responses targeting O-specific polysaccharide (OSP) are associated with protection against Vibrio cholerae O1 infection among household contacts of cholera patients in Bangladesh. PLoS Negl Trop Dis. 2018 04; 12(4):e0006399.
    View in: PubMed
    Score: 0.189
  15. Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers. PLoS Negl Trop Dis. 2018 04; 12(4):e0006376.
    View in: PubMed
    Score: 0.189
  16. Oral immunization with attenuated vaccine strains of Vibrio cholerae expressing a dodecapeptide repeat of the serine-rich Entamoeba histolytica protein fused to the cholera toxin B subunit induces systemic and mucosal antiamebic and anti-V. cholerae antibody responses in mice. Infect Immun. 1997 Aug; 65(8):3118-25.
    View in: PubMed
    Score: 0.180
  17. Protective immunity against Clostridium difficile toxin A induced by oral immunization with a live, attenuated Vibrio cholerae vector strain. Infect Immun. 1997 Jul; 65(7):2941-9.
    View in: PubMed
    Score: 0.179
  18. Plasma and Mucosal Immunoglobulin M, Immunoglobulin A, and Immunoglobulin G Responses to the Vibrio cholerae O1 Protein Immunome in Adults With Cholera in Bangladesh. J Infect Dis. 2017 07 01; 216(1):125-134.
    View in: PubMed
    Score: 0.179
  19. O-Specific Polysaccharide-Specific Memory B Cell Responses in Young Children, Older Children, and Adults Infected with Vibrio cholerae O1 Ogawa in Bangladesh. Clin Vaccine Immunol. 2016 05; 23(5):427-435.
    View in: PubMed
    Score: 0.165
  20. A Cholera Conjugate Vaccine Containing O-specific Polysaccharide (OSP) of V. cholerae O1 Inaba and Recombinant Fragment of Tetanus Toxin Heavy Chain (OSP:rTTHc) Induces Serum, Memory and Lamina Proprial Responses against OSP and Is Protective in Mice. PLoS Negl Trop Dis. 2015; 9(7):e0003881.
    View in: PubMed
    Score: 0.156
  21. Plasma Leptin Levels in Children Hospitalized with Cholera in Bangladesh. Am J Trop Med Hyg. 2015 Aug; 93(2):244-249.
    View in: PubMed
    Score: 0.155
  22. Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis. 2014 Aug; 8(8):e3076.
    View in: PubMed
    Score: 0.147
  23. Evaluation in mice of a conjugate vaccine for cholera made from Vibrio cholerae O1 (Ogawa) O-specific polysaccharide. PLoS Negl Trop Dis. 2014 Feb; 8(2):e2683.
    View in: PubMed
    Score: 0.141
  24. Immunoproteomic analysis of antibody in lymphocyte supernatant in patients with typhoid fever in Bangladesh. Clin Vaccine Immunol. 2014 Mar; 21(3):280-5.
    View in: PubMed
    Score: 0.140
  25. Identification of immunogenic Salmonella enterica serotype Typhi antigens expressed in chronic biliary carriers of S. Typhi in Kathmandu, Nepal. PLoS Negl Trop Dis. 2013; 7(8):e2335.
    View in: PubMed
    Score: 0.136
  26. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2013 Jun; 20(6):780-8.
    View in: PubMed
    Score: 0.133
  27. Identification of in vivo-induced bacterial proteins during human infection with Salmonella enterica serotype Paratyphi A. Clin Vaccine Immunol. 2013 May; 20(5):712-9.
    View in: PubMed
    Score: 0.133
  28. Comparison of immune responses to the O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 in Bangladeshi adult patients with cholera. Clin Vaccine Immunol. 2012 Nov; 19(11):1712-21.
    View in: PubMed
    Score: 0.129
  29. Frequency of reexposure to Vibrio cholerae O1 evaluated by subsequent vibriocidal titer rise after an episode of severe cholera in a highly endemic area in Bangladesh. Am J Trop Med Hyg. 2012 Nov; 87(5):921-6.
    View in: PubMed
    Score: 0.128
  30. Cholera. Lancet. 2012 Jun 30; 379(9835):2466-2476.
    View in: PubMed
    Score: 0.127
  31. Immune responses to cholera in children. Expert Rev Anti Infect Ther. 2012 Apr; 10(4):435-44.
    View in: PubMed
    Score: 0.124
  32. Memory B cell and other immune responses in children receiving two doses of an oral killed cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol. 2012 May; 19(5):690-8.
    View in: PubMed
    Score: 0.124
  33. In vivo expression of Salmonella enterica serotype Typhi genes in the blood of patients with typhoid fever in Bangladesh. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1419.
    View in: PubMed
    Score: 0.122
  34. Comparison of memory B cell, antibody-secreting cell, and plasma antibody responses in young children, older children, and adults with infection caused by Vibrio cholerae O1 El Tor Ogawa in Bangladesh. Clin Vaccine Immunol. 2011 Aug; 18(8):1317-25.
    View in: PubMed
    Score: 0.118
  35. Interferon-? and proliferation responses to Salmonella enterica Serotype Typhi proteins in patients with S. Typhi Bacteremia in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2011 Jun; 5(6):e1193.
    View in: PubMed
    Score: 0.118
  36. Analysis of Salmonella enterica serotype paratyphi A gene expression in the blood of bacteremic patients in Bangladesh. PLoS Negl Trop Dis. 2010 Dec 07; 4(12):e908.
    View in: PubMed
    Score: 0.114
  37. Characterization of anti-Salmonella enterica serotype Typhi antibody responses in bacteremic Bangladeshi patients by an immunoaffinity proteomics-based technology. Clin Vaccine Immunol. 2010 Aug; 17(8):1188-95.
    View in: PubMed
    Score: 0.110
  38. Development of immunoglobulin M memory to both a T-cell-independent and a T-cell-dependent antigen following infection with Vibrio cholerae O1 in Bangladesh. Infect Immun. 2010 Jan; 78(1):253-9.
    View in: PubMed
    Score: 0.105
  39. Comparative proteomic analysis of the PhoP regulon in Salmonella enterica serovar Typhi versus Typhimurium. PLoS One. 2009 Sep 10; 4(9):e6994.
    View in: PubMed
    Score: 0.104
  40. Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun. 2009 Nov; 77(11):5090-6.
    View in: PubMed
    Score: 0.104
  41. Transcutaneous immunization with a synthetic hexasaccharide-protein conjugate induces anti-Vibrio cholerae lipopolysaccharide responses in mice. Vaccine. 2009 Aug 06; 27(36):4917-22.
    View in: PubMed
    Score: 0.103
  42. Immunologic responses to Vibrio cholerae in patients co-infected with intestinal parasites in Bangladesh. PLoS Negl Trop Dis. 2009; 3(3):e403.
    View in: PubMed
    Score: 0.101
  43. A variant in long palate, lung and nasal epithelium clone 1 is associated with cholera in a Bangladeshi population. Genes Immun. 2009 Apr; 10(3):267-72.
    View in: PubMed
    Score: 0.100
  44. Cholera toxin-specific memory B cell responses are induced in patients with dehydrating diarrhea caused by Vibrio cholerae O1. J Infect Dis. 2008 Oct 01; 198(7):1055-61.
    View in: PubMed
    Score: 0.098
  45. Proteomic analysis of Vibrio cholerae in human stool. Infect Immun. 2008 Sep; 76(9):4145-51.
    View in: PubMed
    Score: 0.096
  46. Susceptibility to Vibrio cholerae infection in a cohort of household contacts of patients with cholera in Bangladesh. PLoS Negl Trop Dis. 2008 Apr 09; 2(4):e221.
    View in: PubMed
    Score: 0.094
  47. Application of in vivo induced antigen technology (IVIAT) to Bacillus anthracis. PLoS One. 2008 Mar 19; 3(3):e1824.
    View in: PubMed
    Score: 0.094
  48. Complexity of rice-water stool from patients with Vibrio cholerae plays a role in the transmission of infectious diarrhea. Proc Natl Acad Sci U S A. 2007 Nov 27; 104(48):19091-6.
    View in: PubMed
    Score: 0.092
  49. Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice. Infect Immun. 2007 Jun; 75(6):2826-32.
    View in: PubMed
    Score: 0.088
  50. Transcutaneous immunization with toxin-coregulated pilin A induces protective immunity against Vibrio cholerae O1 El Tor challenge in mice. Infect Immun. 2006 Oct; 74(10):5834-9.
    View in: PubMed
    Score: 0.085
  51. Identification of in vivo-induced bacterial protein antigens during human infection with Salmonella enterica serovar Typhi. Infect Immun. 2006 Sep; 74(9):5161-8.
    View in: PubMed
    Score: 0.085
  52. Live attenuated oral cholera vaccines. Expert Rev Vaccines. 2006 Aug; 5(4):483-94.
    View in: PubMed
    Score: 0.084
  53. Diarrheal epidemics in Dhaka, Bangladesh, during three consecutive floods: 1988, 1998, and 2004. Am J Trop Med Hyg. 2006 Jun; 74(6):1067-73.
    View in: PubMed
    Score: 0.083
  54. Postgenomic approaches to cholera vaccine development. Expert Rev Vaccines. 2006 Jun; 5(3):337-46.
    View in: PubMed
    Score: 0.083
  55. Blood group, immunity, and risk of infection with Vibrio cholerae in an area of endemicity. Infect Immun. 2005 Nov; 73(11):7422-7.
    View in: PubMed
    Score: 0.080
  56. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh. Infect Immun. 2005 Oct; 73(10):6577-83.
    View in: PubMed
    Score: 0.079
  57. Hyperinfectivity of human-passaged Vibrio cholerae can be modeled by growth in the infant mouse. Infect Immun. 2005 Oct; 73(10):6674-9.
    View in: PubMed
    Score: 0.079
  58. Transcriptional profiling of Vibrio cholerae recovered directly from patient specimens during early and late stages of human infection. Infect Immun. 2005 Aug; 73(8):4488-93.
    View in: PubMed
    Score: 0.078
  59. In vivo induced antigen technology (IVIAT). Cell Microbiol. 2005 Jan; 7(1):1-9.
    View in: PubMed
    Score: 0.075
  60. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh. J Infect Dis. 2004 Jun 15; 189(12):2318-22.
    View in: PubMed
    Score: 0.072
  61. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect Immun. 2003 Aug; 71(8):4808-14.
    View in: PubMed
    Score: 0.068
  62. Use of in vivo-induced antigen technology (IVIAT) to identify genes uniquely expressed during human infection with Vibrio cholerae. Proc Natl Acad Sci U S A. 2003 Jul 08; 100(14):8508-13.
    View in: PubMed
    Score: 0.068
  63. Comparison of mucosal and systemic humoral immune responses after transcutaneous and oral immunization strategies. Vaccine. 2002 Jun 21; 20(21-22):2720-6.
    View in: PubMed
    Score: 0.063
  64. Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2022 01; 16(1):e0010102.
    View in: PubMed
    Score: 0.061
  65. Coronavirus Disease 2019 (COVID-19) Diagnostic Clinical Decision Support: A Pre-Post Implementation Study of CORAL (COvid Risk cALculator). Clin Infect Dis. 2021 12 16; 73(12):2248-2256.
    View in: PubMed
    Score: 0.061
  66. A Combination of Metagenomic and Cultivation Approaches Reveals Hypermutator Phenotypes within Vibrio cholerae-Infected Patients. mSystems. 2021 Aug 31; 6(4):e0088921.
    View in: PubMed
    Score: 0.060
  67. Vibrio cholerae Sialidase-Specific Immune Responses Are Associated with Protection against Cholera. mSphere. 2021 04 28; 6(2).
    View in: PubMed
    Score: 0.058
  68. An assessment of potential biomarkers of environment enteropathy and its association with age and microbial infections among children in Bangladesh. PLoS One. 2021; 16(4):e0250446.
    View in: PubMed
    Score: 0.058
  69. Impact of Immunoglobulin Isotype and Epitope on the Functional Properties of Vibrio cholerae O-Specific Polysaccharide-Specific Monoclonal Antibodies. mBio. 2021 04 20; 12(2).
    View in: PubMed
    Score: 0.058
  70. Clostridium difficile--Associated diarrhea: A review. Arch Intern Med. 2001 Feb 26; 161(4):525-33.
    View in: PubMed
    Score: 0.058
  71. Predicting Vibrio cholerae Infection and Disease Severity Using Metagenomics in a Prospective Cohort Study. J Infect Dis. 2021 02 03; 223(2):342-351.
    View in: PubMed
    Score: 0.057
  72. Persistence and decay of human antibody responses to the receptor binding domain of SARS-CoV-2 spike protein in COVID-19 patients. Sci Immunol. 2020 10 08; 5(52).
    View in: PubMed
    Score: 0.056
  73. Antibody responses after COVID-19 infection in patients who are mildly symptomatic or asymptomatic in Bangladesh. Int J Infect Dis. 2020 Dec; 101:220-225.
    View in: PubMed
    Score: 0.056
  74. Dynamics and significance of the antibody response to SARS-CoV-2 infection. medRxiv. 2020 Jul 20.
    View in: PubMed
    Score: 0.055
  75. Mortality, morbidity, and microbiology of endemic cholera among hospitalized patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2000 Jul-Aug; 63(1-2):12-20.
    View in: PubMed
    Score: 0.055
  76. Evaluation of a Rapid Point-of-Care Multiplex Immunochromatographic Assay for the Diagnosis of Enteric Fever. mSphere. 2020 06 10; 5(3).
    View in: PubMed
    Score: 0.055
  77. In vitro and in vivo analyses of constitutive and in vivo-induced promoters in attenuated vaccine and vector strains of Vibrio cholerae. Infect Immun. 2000 Mar; 68(3):1171-5.
    View in: PubMed
    Score: 0.054
  78. Optimizing the germfree mouse model for in vivo evaluation of oral Vibrio cholerae vaccine and vector strains. Infect Immun. 2000 Feb; 68(2):977-81.
    View in: PubMed
    Score: 0.054
  79. Posttranslational Regulation of IL-23 Production Distinguishes the Innate Immune Responses to Live Toxigenic versus Heat-Inactivated Vibrio cholerae. mSphere. 2019 08 21; 4(4).
    View in: PubMed
    Score: 0.052
  80. Induction of systemic, mucosal and memory antibody responses targeting Vibrio cholerae O1 O-specific polysaccharide (OSP) in adults following oral vaccination with an oral killed whole cell cholera vaccine in Bangladesh. PLoS Negl Trop Dis. 2019 08; 13(8):e0007634.
    View in: PubMed
    Score: 0.052
  81. Plasma Immunoglobulin A Responses Against 2 Salmonella Typhi Antigens Identify Patients With Typhoid Fever. Clin Infect Dis. 2019 03 05; 68(6):949-955.
    View in: PubMed
    Score: 0.050
  82. Estimating cholera incidence with cross-sectional serology. Sci Transl Med. 2019 02 20; 11(480).
    View in: PubMed
    Score: 0.050
  83. Vibriocidal Titer and Protection From Cholera in Children. Open Forum Infect Dis. 2019 Apr; 6(4):ofz057.
    View in: PubMed
    Score: 0.050
  84. Cognate T and B cell interaction and association of follicular helper T cells with B cell responses in Vibrio cholerae O1 infected Bangladeshi adults. Microbes Infect. 2019 Apr - May; 21(3-4):176-183.
    View in: PubMed
    Score: 0.050
  85. Human Gut Microbiota Predicts Susceptibility to Vibrio cholerae Infection. J Infect Dis. 2018 07 13; 218(4):645-653.
    View in: PubMed
    Score: 0.048
  86. Defining endemic cholera at three levels of spatiotemporal resolution within Bangladesh. Nat Genet. 2018 07; 50(7):951-955.
    View in: PubMed
    Score: 0.048
  87. Development of a new dipstick (Cholkit) for rapid detection of Vibrio cholerae O1 in acute watery diarrheal stools. PLoS Negl Trop Dis. 2018 03; 12(3):e0006286.
    View in: PubMed
    Score: 0.047
  88. Analysis of the Human Mucosal Response to Cholera Reveals Sustained Activation of Innate Immune Signaling Pathways. Infect Immun. 2018 02; 86(2).
    View in: PubMed
    Score: 0.047
  89. Vibrio cholerae genomic diversity within and between patients. Microb Genom. 2017 12; 3(12).
    View in: PubMed
    Score: 0.046
  90. Assessing antigen specific HLA-DR+ antibody secreting cell (DR+ASC) responses in whole blood in enteric infections using an ELISPOT technique. Microbes Infect. 2018 02; 20(2):122-129.
    View in: PubMed
    Score: 0.046
  91. Coexpression of the B subunit of Shiga toxin 1 and EaeA from enterohemorrhagic Escherichia coli in Vibrio cholerae vaccine strains. Infect Immun. 1997 Jun; 65(6):2127-35.
    View in: PubMed
    Score: 0.045
  92. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells. mBio. 2016 12 20; 7(6).
    View in: PubMed
    Score: 0.043
  93. Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children. PLoS Negl Trop Dis. 2016 Nov; 10(11):e0005039.
    View in: PubMed
    Score: 0.043
  94. Development of a germfree mouse model of Vibrio cholerae infection. Infect Immun. 1996 Oct; 64(10):4373-7.
    View in: PubMed
    Score: 0.043
  95. A magneto-DNA nanoparticle system for the rapid and sensitive diagnosis of enteric fever. Sci Rep. 2016 09 08; 6:32878.
    View in: PubMed
    Score: 0.042
  96. Vibrio cholerae Serogroup O139: Isolation from Cholera Patients and Asymptomatic Household Family Members in Bangladesh between 2013 and 2014. PLoS Negl Trop Dis. 2015 Nov; 9(11):e0004183.
    View in: PubMed
    Score: 0.040
  97. Enumeration of Gut-Homing ß7-Positive, Pathogen-Specific Antibody-Secreting Cells in Whole Blood from Enterotoxigenic Escherichia coli- and Vibrio cholerae-Infected Patients, Determined Using an Enzyme-Linked Immunosorbent Spot Assay Technique. Clin Vaccine Immunol. 2016 01; 23(1):27-36.
    View in: PubMed
    Score: 0.040
  98. The increased severity in patients presenting to hospital with diarrhea in Dhaka, Bangladesh since the emergence of the hybrid strain of Vibrio cholerae O1 is not unique to cholera patients. Int J Infect Dis. 2015 Nov; 40:9-14.
    View in: PubMed
    Score: 0.040
  99. Cholera in pregnancy: Clinical and immunological aspects. Int J Infect Dis. 2015 Oct; 39:20-4.
    View in: PubMed
    Score: 0.039
  100. Gut microbial succession follows acute secretory diarrhea in humans. mBio. 2015 May 19; 6(3):e00381-15.
    View in: PubMed
    Score: 0.039
  101. Typhoid fever in young children in Bangladesh: clinical findings, antibiotic susceptibility pattern and immune responses. PLoS Negl Trop Dis. 2015 Apr; 9(4):e0003619.
    View in: PubMed
    Score: 0.038
  102. Comparative proteomic analysis reveals activation of mucosal innate immune signaling pathways during cholera. Infect Immun. 2015 Mar; 83(3):1089-103.
    View in: PubMed
    Score: 0.038
  103. Household Transmission of Vibrio cholerae in Bangladesh. PLoS Negl Trop Dis. 2014 Nov; 8(11):e3314.
    View in: PubMed
    Score: 0.037
  104. Evaluation of matrix-assisted laser desorption ionization-time of flight mass spectrometry for identification of Vibrio cholerae. J Clin Microbiol. 2015 Jan; 53(1):329-31.
    View in: PubMed
    Score: 0.037
  105. Bacterial shedding in household contacts of cholera patients in Dhaka, Bangladesh. Am J Trop Med Hyg. 2014 Oct; 91(4):738-42.
    View in: PubMed
    Score: 0.037
  106. Immunogenicity of a killed bivalent (O1 and O139) whole cell oral cholera vaccine, Shanchol, in Haiti. PLoS Negl Trop Dis. 2014 May; 8(5):e2828.
    View in: PubMed
    Score: 0.036
  107. Antigen-specific memory B-cell responses to enterotoxigenic Escherichia coli infection in Bangladeshi adults. PLoS Negl Trop Dis. 2014 Apr; 8(4):e2822.
    View in: PubMed
    Score: 0.036
  108. Immune responses to O-specific polysaccharide and lipopolysaccharide of Vibrio cholerae O1 Ogawa in adult Bangladeshi recipients of an oral killed cholera vaccine and comparison to responses in patients with cholera. Am J Trop Med Hyg. 2014 May; 90(5):873-81.
    View in: PubMed
    Score: 0.036
  109. Cellular and cytokine responses to Salmonella enterica serotype Typhi proteins in patients with typhoid fever in Bangladesh. Am J Trop Med Hyg. 2014 Jun; 90(6):1024-1030.
    View in: PubMed
    Score: 0.036
  110. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol. 2013 Oct; 20(10):1592-8.
    View in: PubMed
    Score: 0.034
  111. Antibody avidity in humoral immune responses in Bangladeshi children and adults following administration of an oral killed cholera vaccine. Clin Vaccine Immunol. 2013 Oct; 20(10):1541-8.
    View in: PubMed
    Score: 0.034
  112. Evaluation of a typhoid/paratyphoid diagnostic assay (TPTest) detecting anti-Salmonella IgA in secretions of peripheral blood lymphocytes in patients in Dhaka, Bangladesh. PLoS Negl Trop Dis. 2013; 7(7):e2316.
    View in: PubMed
    Score: 0.034
  113. Natural selection in a bangladeshi population from the cholera-endemic ganges river delta. Sci Transl Med. 2013 Jul 03; 5(192):192ra86.
    View in: PubMed
    Score: 0.034
  114. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection. Clin Vaccine Immunol. 2013 Jan; 20(1):17-23.
    View in: PubMed
    Score: 0.032
  115. High depth, whole-genome sequencing of cholera isolates from Haiti and the Dominican Republic. BMC Genomics. 2012 Sep 11; 13:468.
    View in: PubMed
    Score: 0.032
  116. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2012 Aug; 19(8):1304-11.
    View in: PubMed
    Score: 0.032
  117. Memory B cell responses to Vibrio cholerae O1 lipopolysaccharide are associated with protection against infection from household contacts of patients with cholera in Bangladesh. Clin Vaccine Immunol. 2012 Jun; 19(6):842-8.
    View in: PubMed
    Score: 0.031
  118. Systemic antibody responses to the immunodominant p23 antigen and p23 polymorphisms in children with cryptosporidiosis in Bangladesh. Am J Trop Med Hyg. 2012 Feb; 86(2):214-22.
    View in: PubMed
    Score: 0.031
  119. Individuals with Le(a+b-) blood group have increased susceptibility to symptomatic vibrio cholerae O1 infection. PLoS Negl Trop Dis. 2011 Dec; 5(12):e1413.
    View in: PubMed
    Score: 0.031
  120. Simple, direct conjugation of bacterial O-SP-core antigens to proteins: development of cholera conjugate vaccines. Bioconjug Chem. 2011 Oct 19; 22(10):2179-85.
    View in: PubMed
    Score: 0.030
  121. LPLUNC1 modulates innate immune responses to Vibrio cholerae. J Infect Dis. 2011 Nov; 204(9):1349-57.
    View in: PubMed
    Score: 0.030
  122. Antibody responses to the immunodominant Cryptosporidium gp15 antigen and gp15 polymorphisms in a case-control study of cryptosporidiosis in children in Bangladesh. Am J Trop Med Hyg. 2011 Jul; 85(1):97-104.
    View in: PubMed
    Score: 0.030
  123. Vibrio cholerae O1 infection induces proinflammatory CD4+ T-cell responses in blood and intestinal mucosa of infected humans. Clin Vaccine Immunol. 2011 Aug; 18(8):1371-7.
    View in: PubMed
    Score: 0.029
  124. Meeting cholera's challenge to Haiti and the world: a joint statement on cholera prevention and care. PLoS Negl Trop Dis. 2011; 5(5):e1145.
    View in: PubMed
    Score: 0.029
  125. Genetic diversity of Cryptosporidium spp. from Bangladeshi children. J Clin Microbiol. 2011 Jun; 49(6):2307-10.
    View in: PubMed
    Score: 0.029
  126. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol. 2011 May; 18(5):844-50.
    View in: PubMed
    Score: 0.029
  127. Mucosal immunologic responses in cholera patients in Bangladesh. Clin Vaccine Immunol. 2011 Mar; 18(3):506-12.
    View in: PubMed
    Score: 0.029
  128. Relatedness of Vibrio cholerae O1/O139 isolates from patients and their household contacts, determined by multilocus variable-number tandem-repeat analysis. J Bacteriol. 2010 Sep; 192(17):4367-76.
    View in: PubMed
    Score: 0.028
  129. Concomitant enterotoxigenic Escherichia coli infection induces increased immune responses to Vibrio cholerae O1 antigens in patients with cholera in Bangladesh. Infect Immun. 2010 May; 78(5):2117-24.
    View in: PubMed
    Score: 0.027
  130. Comparison of clinical features and immunological parameters of patients with dehydrating diarrhoea infected with Inaba or Ogawa serotypes of Vibrio cholerae O1. Scand J Infect Dis. 2010; 42(1):48-56.
    View in: PubMed
    Score: 0.027
  131. Familial aggregation of Vibrio cholerae-associated infection in Matlab, Bangladesh. J Health Popul Nutr. 2009 Dec; 27(6):733-8.
    View in: PubMed
    Score: 0.026
  132. Clinical outcomes in household contacts of patients with cholera in Bangladesh. Clin Infect Dis. 2009 Nov 15; 49(10):1473-9.
    View in: PubMed
    Score: 0.026
  133. Salmonella enterica serovar Typhi-specific immunoglobulin A antibody responses in plasma and antibody in lymphocyte supernatant specimens in Bangladeshi patients with suspected typhoid fever. Clin Vaccine Immunol. 2009 Nov; 16(11):1587-94.
    View in: PubMed
    Score: 0.026
  134. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun. 2009 Sep; 77(9):3850-6.
    View in: PubMed
    Score: 0.026
  135. A comparison of clinical and immunologic features in children and older patients hospitalized with severe cholera in Bangladesh. Pediatr Infect Dis J. 2008 Nov; 27(11):986-92.
    View in: PubMed
    Score: 0.025
  136. Shifting prevalence of major diarrheal pathogens in patients seeking hospital care during floods in 1998, 2004, and 2007 in Dhaka, Bangladesh. Am J Trop Med Hyg. 2008 Nov; 79(5):708-14.
    View in: PubMed
    Score: 0.025
  137. Cryptosporidiosis among Bangladeshi children with diarrhea: a prospective, matched, case-control study of clinical features, epidemiology and systemic antibody responses. Am J Trop Med Hyg. 2004 Oct; 71(4):412-9.
    View in: PubMed
    Score: 0.018
  138. The major subunit of the toxin-coregulated pilus TcpA induces mucosal and systemic immunoglobulin A immune responses in patients with cholera caused by Vibrio cholerae O1 and O139. Infect Immun. 2004 Aug; 72(8):4448-54.
    View in: PubMed
    Score: 0.018
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.